510(k) K190219

Simplexa VZV Direct, Simplexa VZV Positive Control Pack by Diasorin Molecular, LLC — Product Code PLO

K190219 is an FDA 510(k) premarket notification submitted by Diasorin Molecular, LLC for the device "Simplexa VZV Direct, Simplexa VZV Positive Control Pack". The FDA issued a decision of Substantially Equivalent on May 13, 2019. The device falls under product code PLO (Meningitis/Encephalitis Pathogen Multiplex Nucleic Acid Detection System), a Class II device regulated under 21 CFR 866.3970. Diasorin Molecular, LLC has 13 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
May 13, 2019
Date Received
Feb 4, 2019
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Meningitis/Encephalitis Pathogen Multiplex Nucleic Acid Detection System
Device Class
Class II
Regulation Number
866.3970
Review Panel
MI
Submission Type
510(k)

A meningitis/encephalitis pathogen multiplex nucleic acid detection system is a qualitative in vitro diagnostic test for the direct detection and identification of microbial-associated nucleic acids in cerebrospinal fluid. The test is indicated for individuals with signs and symptoms of meningitis or encephalitis and aids in diagnosis of agents of meningitis or encephalitis when used in conjunction with clinical and other laboratory findings.

Need the full FDA record for Diasorin Molecular, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K190219. Report a data issue: hello@regdatalab.com.